دراسة: أدوية جي.إل.بي-1 قد تتفوق على الميتفورمين بمرحلة ما قبل السكري
دراسة: أدوية جي.إل.بي-1 قد تتفوق على الميتفورمين بمرحلة ما قبل السكري 3 نوفمبر تشرين الثاني (رويترز
Related stories
Crédit Mutuel Arkéa Contains Cyberattack; Operations Gradually Resume
The bank said clients’ assets were not affected.
M impact | EQUITY | Nov 04, 2026, 01:22 PM UTC
Crédit Mutuel Arkéa Contains Cyberattack as Operations Gradually Resume
The bank said clients’ assets have not been affected.
M impact | EQUITY | Nov 04, 2026, 01:22 PM UTC
Crédit Mutuel Arkéa Says It Was Targeted in Cyberattack
M impact | EQUITY | Nov 04, 2026, 01:22 PM UTC
Circle Reports $865 Million in Q3 Revenue and Reserve Income
Circle reported third-quarter revenue and reserve income of $865 million, up 17% year over year. Net income from continuing operations was $226 million, compared with $214.4 millio
M impact | EQUITY | Nov 04, 2026, 01:21 PM UTC
Trinity Capital reports Q3 profit
M impact | EQUITY | Nov 04, 2026, 01:21 PM UTC
Harmony Biosciences Reports Third-Quarter Revenue of $268.92 Million
Third-quarter 2026 revenue rose 12.3% year over year to $268.92 million, while net income fell 5.2% to $48.2 million and diluted EPS declined 6.9% to $0.81.
M impact | EQUITY | Nov 04, 2026, 01:21 PM UTC